World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
112
Citations
49233
World Ranking
808
National Ranking
491

Medicine

D-Index
113
Citations
51469
World Ranking
4917
National Ranking
2663

Madeleine Duvic publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Madeleine Duvic sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 844 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Madeleine Duvic D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Madeleine Duvic sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Madeleine Duvic is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine with a considerable emphasis on dermatology, pathology and forensic medicine, epidemiology, oncology, and immunology.

The main topics covered in their work include cutaneous lymphoproliferative disorders research, lymphoma diagnosis and treatment, CAR-T cell therapy research, T-cell and retrovirus studies, fungal infections and studies, nail diseases and treatments, as well as autoimmune and inflammatory disorders.

Key recent papers authored or coauthored by Madeleine Duvic include:

  • Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC, 2021, Blood
  • Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options, 2021, American Journal of Clinical Dermatology
  • New Practical Aspects of Sweet Syndrome, 2022, American Journal of Clinical Dermatology
  • Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data, 2021, Blood Advances
  • Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis, 2021, European Journal of Cancer

Frequent coauthors who have contributed significantly to research alongside Madeleine Duvic include Auris Huen, Tejas P. Joshi, Youn H. Kim, Larisa J. Geskin, and Carlos A. Torres-Cabala.

Madeleine Duvic's work has been published notably in several scientific venues, reflecting their engagement in dermatological and oncological research. Frequent publication venues include:

  • Journal of the American Academy of Dermatology
  • European Journal of Cancer
  • Blood
  • American Journal of Clinical Dermatology
  • Clinical Lymphoma Myeloma & Leukemia

Best Publications

  • Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

    Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze

  • Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

    Madeleine Duvic;Rakshandra Talpur;Xiao Ni;Chunlei Zhang

  • Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

    Elise A. Olsen;Youn H. Kim;Timothy M. Kuzel;Theresa R. Pacheco

  • Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

    Madeleine Duvic;Kenneth Hymes;Peter Heald;Debra Breneman

  • Genome-wide association study in alopecia areata implicates both innate and adaptive immunity

    Lynn Petukhova;Madeleine Duvic;Maria Hordinsky;David Norris

  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

    Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic

  • Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

    Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook

  • Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

    Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim

  • Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.

    Eric C. Vonderheid;Maria Grazia Bernengo;Günter Burg;Madeleine Duvic

  • Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma

    Madeleine Duvic;Ann G. Martin;Youn Kim;Elise Olsen

  • Guidelines of care for the management of primary cutaneous melanoma

    Christopher K. Bichakjian;Allan C. Halpern;Timothy M. Johnson;Antoinette Foote Hood

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

  • European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

    Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot

  • EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

    Werner Kempf;Katrin Pfaltz;Maarten H. Vermeer;Antonio Cozzio

  • Mortality Risk From Squamous Cell Skin Cancer

    Gary L. Clayman;J. Jack Lee;F. Christopher Holsinger;Xian Zhou

  • Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.

    Madeleine Duvic;Jenny Vu

  • Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Julia J. Scarisbrick;H. Miles Prince;Maarten H. Vermeer;Pietro Quaglino

  • Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin

    Sunil Nagpal;Sheetal Patel;Heidi Jacobe;Daniel DiSepio

  • Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis

    Eleni Diamandidou;Maria Colome-Grimmer;Luis Fayad;Madeleine Duvic

  • Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

    Naveen Pemmaraju;Andrew A. Lane;Kendra L. Sweet;Anthony S. Stein

Frequent Co-Authors

Youn H. Kim
Youn H. Kim Stanford University
Victor G. Prieto
Victor G. Prieto The University of Texas MD Anderson Cancer Center
Sean Whittaker
Sean Whittaker King's College London
Dan Jones
Dan Jones The Ohio State University
Timothy M. Kuzel
Timothy M. Kuzel Rush University Medical Center
Qingyi Wei
Qingyi Wei Duke University
Reinhard Dummer
Reinhard Dummer University of Zurich
H. Miles Prince
H. Miles Prince Peter MacCallum Cancer Centre
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a wide range of related online degrees and career pathways. If you’re interested in the business side of healthcare, pursuing a masters in healthcare administration cost can be a smart investment, with affordable programs now available to suit different budgets.

Nursing professionals seeking advanced roles may consider the cheapest bsn to dnp programs online. These programs prepare students for leadership and specialized clinical positions without putting financial strain on working nurses.

If pharmacy is your passion, you can now access flexible online pharmacy schools that help you earn your degree while balancing work and personal commitments.

Finally, those interested in the digital transformation of healthcare can check out online health information management degree programs, which prepare you to manage sensitive patient data and navigate evolving healthcare technologies.

These diverse online options can help you shape a medical career that fits your interests, schedule, and budget.

Best Scientists Citing Madeleine Duvic

Trending Scientists

Recently Published Articles